NEI Research News

Scientists have evidence that variants of the same gene that enables us to make connective tissue by crosslinking proteins is associated with unusual glaucoma.

National Eye Institute (NEI) Postdoctoral Fellow Aman George, Ph.D., has received a $65,000 grant from the Knights Templar Eye Foundation to identify new drug treatments for vision impairment in children with a type of albinism.

U. Delaware's Salil Lachke identifies new mechanism essential for eye lens development.

Researchers at the National Eye Institute have discovered cellular mechanisms that help the 13-lined ground squirrel survive hibernation.

Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study in mice from scientists at the National Eye Institute (NEI).

A competition for radical ideas in the fight against blindness will move to its next phase by challenging participants to build functioning human retina prototypes.

The recent approval of two novel medications for glaucoma – the first new medications for the disorder in nearly 18 years – are fruit borne from decades of foundational scientific research supported by the National Eye Institute (NEI).

Common, unavoidable eye movements may be a cause of glaucoma in people with normal intraocular pressure (normal-tension glaucoma), according to new research supported by the National Eye Institute.

In a major step forward in the battle against macular degeneration, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight.

A protein shaped like a 'Y' made NEI-funded scientists at Georgia Tech do a double-take may change the way they think about the protein which is sometimes implicated in glaucoma.